Abstract
Introduction: Sarcopenia and vitamin D deficiency are highly prevalent among patients undergoing haemodialysis. Although vitamin D deficiency, assessed using serum 25-hydroxyvitamin D (25(OH)D) levels, is known to be associated with sarcopenia in the general population, whether serum 25(OH)D levels are associated with sarcopenia in patients undergoing haemodialysis with suppressed renal activation of 25(OH)D remains unclear. This study aimed to examine the association between serum 25(OH)D levels and sarcopenia in patients undergoing haemodialysis. Methods: Serum 25(OH)D level measurements and assessment of sarcopenia using the Asian Working Group for Sarcopenia criteria were conducted in 95 stable outpatients undergoing maintenance haemodialysis therapy. Results: Sarcopenia was observed in 22 (23.1%) patients. In multiple logistic regression analysis, serum 25(OH)D levels were associated with sarcopenia (odds ratio [OR] 0.87, 95% confidence interval [CI] 0.77–0.99, p = 0.039) independent of traditional risk factors for sarcopenia. In multiple linear regression analyses, serum 25(OH)D levels were associated with parameters of skeletal muscle mass and strength (β = 0.145, p = 0.046, and β = 0.194, p = 0.020, respectively). The adjusted OR for sarcopenia was 5.60 (95% CI 1.52–20.57, p = 0.009) in the vitamin D deficiency group categorized based on the cut-off serum 25(OH)D level of 10 ng/mL. Regarding model discrimination, adding vitamin D deficiency to the traditional risk factors significantly improved the integrated discrimination improvement score (0.093, p = 0.007). Conclusion: Lower serum 25(OH)D levels were associated with sarcopenia independent of traditional risk factors in patients undergoing haemodialysis with suppressed vitamin D activation in the kidney. This finding implies that circulating 25(OH)D may have an important relationship with the skeletal muscle function of patients undergoing haemodialysis, and its measurement may be recommended to identify patients at high risk for sarcopenia among those undergoing haemodialysis.
Journal Section:
Brief Report
References
1.
Cruz-Jentoft
AJ
, Sayer
AA
. Sarcopenia
. Lancet
. 2019
;393
(10191
):2636
–46
. .2.
Dent
E
, Morley
JE
, Cruz-Jentoft
AJ
, Arai
H
, Kritchevsky
SB
, Guralnik
J
, et al. International clinical practice guidelines for sarcopenia (ICFSR): screening, diagnosis and management
. J Nutr Health Aging
. 2018
;22
(10
):1148
–61
. .3.
Ren
H
, Gong
D
, Jia
F
, Xu
B
, Liu
Z
. Sarcopenia in patients undergoing maintenance hemodialysis: incidence rate, risk factors and its effect on survival risk
. Ren Fail
. 2016
;38
(3
):364
–71
. .4.
Isoyama
N
, Qureshi
AR
, Avesani
CM
, Lindholm
B
, Bàràny
P
, Heimbürger
O
, et al. Comparative associations of muscle mass and muscle strength with mortality in dialysis patients
. Clin J Am Soc Nephrol
. 2014
;9
(10
):1720
–8
. .5.
Mori
K
, Nishide
K
, Okuno
S
, Shoji
T
, Emoto
M
, Tsuda
A
, et al. Impact of diabetes on sarcopenia and mortality in patients undergoing hemodialysis
. BMC Nephrol
. 2019
;20
(1
):105
. .6.
Kim
JK
, Kim
SG
, Oh
JE
, Lee
YK
, Noh
JW
, Kim
HJ
, et al. Impact of sarcopenia on long-term mortality and cardiovascular events in patients undergoing hemodialysis
. Korean J Intern Med
. 2019
;34
(3
):599
–607
. .7.
Remelli
F
, Vitali
A
, Zurlo
A
, Volpato
S
. Vitamin D deficiency and sarcopenia in older persons
. Nutrients
. 2019
;11
(12
):2861
. .8.
Visser
M
, Deeg
DJ
, Lips
P
; Longitudinal Aging Study Amsterdam
. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam
. J Clin Endocrinol Metab
. 2003
;88
(12
):5766
–72
. .9.
Dhesi
JK
, Bearne
LM
, Moniz
C
, Hurley
MV
, Jackson
SH
, Swift
CG
, et al. Neuromuscular and psychomotor function in elderly subjects who fall and the relationship with vitamin D status
. J Bone Miner Res
. 2002
;17
(5
):891
–7
. .10.
Jean
G
, Souberbielle
JC
, Chazot
C
. Vitamin D in chronic kidney disease and dialysis patients
. Nutrients
. 2017
;9
(4
):328
. .11.
Bataille
S
, Landrier
JF
, Astier
J
, Giaime
P
, Sampol
J
, Sichez
H
, et al. The “dose-effect” relationship between 25-hydroxyvitamin D and muscle strength in hemodialysis patients favors a normal threshold of 30 ng/mL for plasma 25-hydroxyvitamin D
. J Ren Nutr
. 2016
;26
(1
):45
–52
. .12.
Boudville
N
, Inderjeeth
C
, Elder
GJ
, Glendenning
P
. Association between 25-hydroxyvitamin D, somatic muscle weakness and falls risk in end-stage renal failure
. Clin Endocrinol
. 2010
;73
(3
):299
–304
. .13.
Liu
J
, Huang
Z
, Gilbertson
DT
, Foley
RN
, Collins
AJ
. An improved comorbidity index for outcome analyses among dialysis patients
. Kidney Int
. 2010
;77
(2
):141
–51
. .14.
Chen
LK
, Liu
LK
, Woo
J
, Assantachai
P
, Auyeung
TW
, Bahyah
KS
, et al. Sarcopenia in asia: consensus report of the asian working group for sarcopenia
. J Am Med Dir Assoc
. 2014
;15
(2
):95
–101
. .15.
Guralnik
JM
, Simonsick
EM
, Ferrucci
L
, Glynn
RJ
, Berkman
LF
, Blazer
DG
, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission
. J Gerontol
. 1994
;49
(2
):M85
–M94
. .16.
Landi
F
, Liperoti
R
, Fusco
D
, Mastropaolo
S
, Quattrociocchi
D
, Proia
A
, et al. Prevalence and risk factors of sarcopenia among nursing home older residents
. J Gerontol A Biol Sci Med Sci
. 2012
;67
(1
):48
–55
. .17.
Marzetti
E
, Calvani
R
, Tosato
M
, Cesari
M
, Di Bari
M
, Cherubini
A
, et al. Sarcopenia: an overview
. Aging Clin Exp Res
. 2017
;29
(1
):11
–7
. .18.
Rosen
CJ
. Clinical practice. Vitamin D insufficiency
. N Engl J Med
. 2011
;364
(3
):248
–54
. .19.
20.
DeLong
ER
, DeLong
DM
, Clarke-Pearson
DL
. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach
. Biometrics
. 1988
;44
(3
):837
–45
. .21.
Pencina
MJ
, D’Agostino
RB
, D’Agostino
RB
, Vasan
RS
. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond
. Stat Med
. 2008
;27
(2
):157
–72
. .22.
Hanafusa
N
, Abe
M
, Joki
N
, Ogawa
T
, Kanda
E
, Kikuchi
K
, et al. Annual dialysis data report 2019, JSDT renal data registry
. Ren Replace Ther
. 2023
;9
(1
):47
. .23.
Holick
MF
. Vitamin D deficiency
. N Engl J Med
. 2007
;357
(3
):266
–81
. .24.
Slatopolsky
E
, Weerts
C
, Thielan
J
, Horst
R
, Harter
H
, Martin
KJ
. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients
. J Clin Invest
. 1984
;74
(6
):2136
–43
. .25.
Simpson
RU
, Thomas
GA
, Arnold
AJ
. Identification of 1,25-dihydroxyvitamin D3 receptors and activities in muscle
. J Biol Chem
. 1985
;260
(15
):8882
–91
. .26.
Townsend
K
, Evans
KN
, Campbell
MJ
, Colston
KW
, Adams
JS
, Hewison
M
. Biological actions of extra-renal 25-hydroxyvitamin D-1alpha-hydroxylase and implications for chemoprevention and treatment
. J Steroid Biochem Mol Biol
. 2005
;97
(1–2
):103
–9
. .27.
Gallieni
M
, Kamimura
S
, Ahmed
A
, Bravo
E
, Delmez
J
, Slatopolsky
E
, et al. Kinetics of monocyte 1 alpha-hydroxylase in renal failure
. Am J Physiol
. 1995
;268
(4 Pt 2
):F746
–53
. .28.
Srikuea
R
, Zhang
X
, Park-Sarge
OK
, Esser
KA
. VDR and CYP27B1 are expressed in C2C12 cells and regenerating skeletal muscle: potential role in suppression of myoblast proliferation
. Am J Physiol Cell Physiol
. 2012
;303
(4
):C396
–405
. .29.
Girgis
CM
, Mokbel
N
, Cha
KM
, Houweling
PJ
, Abboud
M
, Fraser
DR
, et al. The vitamin D receptor (VDR) is expressed in skeletal muscle of male mice and modulates 25-hydroxyvitamin D (25OHD) uptake in myofibers
. Endocrinology
. 2014
;155
(9
):3227
–37
. .30.
Girgis
CM
, Cha
KM
, So
B
, Tsang
M
, Chen
J
, Houweling
PJ
, et al. Mice with myocyte deletion of vitamin D receptor have sarcopenia and impaired muscle function
. J Cachexia Sarcopenia Muscle
. 2019
;10
(6
):1228
–40
. .31.
Caravaca-Fontán
F
, Gonzales-Candia
B
, Luna
E
, Caravaca
F
. Relative importance of the determinants of serum levels of 25-hydroxy vitamin D in patients with chronic kidney disease
. Nefrologia
. 2016 Sep-Oct
;36
(5
):510
–6
. .32.
Nakamura
K
, Nashimoto
M
, Matsuyama
S
, Yamamoto
M
. Low serum concentrations of 25-hydroxyvitamin D in young adult Japanese women: a cross sectional study
. Nutrition
. 2001 Nov-Dec
;17
(11–12
):921
–5
. .33.
Yoshimura
N
, Muraki
S
, Oka
H
, Morita
M
, Yamada
H
, Tanaka
S
, et al. Profiles of vitamin D insufficiency and deficiency in Japanese men and women: association with biological, environmental, and nutritional factors and coexisting disorders: the ROAD study
. Osteoporos Int
. 2013
;24
(11
):2775
–87
. .34.
Nakamura
K
, Kitamura
K
, Takachi
R
, Saito
T
, Kobayashi
R
, Oshiki
R
, et al. Impact of demographic, environmental, and lifestyle factors on vitamin D sufficiency in 9084 Japanese adults
. Bone
. 2015
;74
:10
–7
. .35.
Nakamura
K
, Nashimoto
M
, Okuda
Y
, Ota
T
, Yamamoto
M
. Fish as a major source of vitamin D in the Japanese diet
. Nutrition
. 2002
;18
(5
):415
–6
. .© 2024 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2024
You do not currently have access to this content.
